Nemaura Medical (NMRD) Stock Chart & Stock Price History → Could this Tiny Biotech End Disease Forever? (From Behind the Markets) (Ad) Free NMRD Stock Alerts $0.03 0.00 (-0.90%) (As of 02:43 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Nemaura Medical Stock Price Performance5 Day Performance-23.26%1 Month Performance-61.18%3 Month Performance-56.58%6 Month Performance-87.35%Year-To-Date Performance-84.93%1 Year Performance-95.76% Receive NMRD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nemaura Medical and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. NMRD Stock Chart for Wednesday, May, 8, 2024 NMRD Chart by TradingView Nemaura Medical Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$0.03$0.03+11.00%$0.04$0.031,062 shs$1.34 million05/06/2024$0.04$0.03-30.24%$0.04$0.03222,367 shs$1.21 million05/03/2024$0.04$0.04+11.70%$0.05$0.0427,480 shs$1.74 million05/02/2024$0.05$0.04-27.97%$0.05$0.03219,822 shs$1.55 million05/01/2024$0.06$0.05-10.77%$0.06$0.0510,839 shs$2.16 million04/30/2024$0.05$0.06+9.11%$0.06$0.056,405 shs$2.42 million Get the Latest News and Ratings for NMRD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nemaura Medical and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$0.05$0.05+1.29%$0.05$0.0530,812 shs$2.22 million04/26/2024$0.06$0.05-4.39%$0.06$0.0510,833 shs$2.19 million04/25/2024$0.07$0.06-12.78%$0.07$0.0582,647 shs$2.29 million04/24/2024$0.07$0.07-9.72%$0.08$0.0644,065 shs$2.62 million04/23/2024$0.07$0.07$0.07$0.0642,662 shs$2.91 million04/22/2024$0.08$0.07-14.34%$0.08$0.0742,662 shs$2.91 million04/19/2024$0.08$0.08+5.39%$0.09$0.0711,913 shs$2.43 million04/18/2024$0.08$0.08+5.00%$0.09$0.0727,920 shs$2.31 million04/17/2024$0.07$0.08+2.56%$0.10$0.0729,302 shs$2.20 million04/16/2024$0.07$0.07-0.54%$0.10$0.0728,054 shs$2.14 million04/15/2024$0.09$0.07-12.35%$0.10$0.0716,268 shs$2.15 million04/12/2024$0.09$0.09$0.09$0.093,503 shs$2.54 million04/11/2024$0.09$0.09+3.53%$0.09$0.093,503 shs$2.54 million04/10/2024$0.08$0.09+3.53%$0.10$0.094,991 shs$2.46 million04/09/2024$0.09$0.08-3.41%$0.10$0.0812,970 shs$2.37 million04/08/2024$0.09$0.09$0.09$0.0815,366 shs$2.46 million04/05/2024$0.08$0.09+6.25%$0.09$0.0715,366 shs$2.46 million04/04/2024$0.07$0.08+12.68%$0.10$0.0820,135 shs$2.31 million04/03/2024$0.09$0.07-21.02%$0.08$0.0710,613 shs$2.05 million04/02/2024$0.09$0.09+1.01%$0.09$0.079,529 shs$2.60 million04/01/2024$0.09$0.09$0.09$0.083,464 shs$2.57 million03/29/2024$0.09$0.09$0.09$0.083,464 shs$2.57 million03/28/2024$0.08$0.09+11.11%$0.09$0.083,462 shs$2.57 million03/27/2024$0.08$0.08-5.48%$0.09$0.084,605 shs$2.32 million03/26/2024$0.09$0.08-3.65%$0.08$0.081,351 shs$2.45 million03/25/2024$0.08$0.09+3.69%$0.09$0.081,286 shs$2.54 million03/22/2024$0.07$0.08+15.85%$0.09$0.0724,466 shs$2.45 million03/21/2024$0.08$0.07-5.55%$0.09$0.075,317 shs$2.12 million03/20/2024$0.08$0.08$0.08$0.081,588 shs$2.24 million03/19/2024$0.08$0.08-3.13%$0.09$0.07252,973 shs$2.24 million03/18/2024$0.08$0.08-2.68%$0.09$0.0813,000 shs$2.31 million03/15/2024$0.08$0.08$0.08$0.085,609 shs$2.23 million03/14/2024$0.08$0.08$0.08$0.083,340 shs$2.23 million03/13/2024$0.08$0.08-1.66%$0.09$0.084,712 shs$2.23 millionCould this Tiny Biotech End Disease Forever? (Ad)Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now.03/12/2024$0.08$0.08+1.69%$0.09$0.089,541 shs$2.26 million03/11/2024$0.08$0.08$0.09$0.0812,093 shs$2.23 million03/08/2024$0.08$0.08$0.09$0.0814,853 shs$2.23 million03/07/2024$0.08$0.08-0.13%$0.09$0.082,544 shs$2.23 million03/06/2024$0.08$0.08-1.15%$0.10$0.0835,315 shs$2.23 million03/05/2024$0.08$0.08-7.14%$0.09$0.081,344 shs$2.25 million03/04/2024$0.08$0.08+5.00%$0.08$0.0832,132 shs$2.43 million03/01/2024$0.08$0.08+5.12%$0.08$0.085,971 shs$2.31 million02/29/2024$0.08$0.08-6.28%$0.08$0.0824,173 shs$2.20 million02/28/2024$0.09$0.08-6.67%$0.08$0.0812,853 shs$2.35 million02/27/2024$0.09$0.09-4.92%$0.10$0.0826,832 shs$2.51 million02/26/2024$0.10$0.09-10.29%$0.10$0.0929,123 shs$2.64 million02/23/2024$0.10$0.10+2.00%$0.10$0.0939,873 shs$2.95 million02/22/2024$0.09$0.10+11.11%$0.13$0.09591,014 shs$2.89 million02/21/2024$0.08$0.09+18.42%$0.10$0.08160,597 shs$2.60 million02/20/2024$0.08$0.08-8.43%$0.08$0.0812,185 shs$2.20 million02/19/2024$0.08$0.08$0.08$0.08110,500 shs$2.40 million02/16/2024$0.08$0.08+3.88%$0.08$0.08110,559 shs$2.40 million02/15/2024$0.08$0.08+6.39%$0.08$0.0819,732 shs$2.31 million02/14/2024$0.08$0.08+0.13%$0.08$0.083,192 shs$2.17 million02/13/2024$0.08$0.08$0.08$0.0825,153 shs$2.17 million02/12/2024$0.08$0.08-4.82%$0.08$0.0860,225 shs$2.17 million02/09/2024$0.08$0.08+3.68%$0.08$0.086,286 shs$2.28 million02/08/2024$0.08$0.08-5.00%$0.09$0.0899,085 shs$2.20 million02/07/2024$0.08$0.08-0.62%$0.10$0.0815,756 shs$2.31 million Related Companies: DYNT Stock Chart QNRX Stock Chart RSLS Stock Chart INVO Stock Chart TNON Stock Chart OSAP Stock Chart OSA Stock Chart GMVDF Stock Chart IONM Stock Chart BJDX Stock Chart Receive NMRD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nemaura Medical and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NMRD) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersAI “wealth window” is closing June 25thParadigm PressElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe AI Stock that’s Disrupting Every IndustryStockEarningsShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsCharles Payne Demystifies OptionsUnstoppable ProsperityWatch this FREE trading tutorial while it’s still availableInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nemaura Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.